New concept of de-escalation management strategy in breast cancer patients with 1-2 positive sentinel lymph nodes
In the era of sentinel lymph node biopsy (SLNB), the axillary management concept that 1-2 positive sentinel lymph node (SLN) could safely omit axillary lymph node dissection (ALND) are gradually being accepted by more and more patients.The omission of ALND is safe with no difference in Toddler Hats regional recurrence in early breast cancer patient